Is Donaldson Company (DCI) Undervalued As Strong Results And 2027 Outlook Lift Expectations?

Donaldson Company (DCI) drew investor attention after reporting higher year over year sales and net income for its fourth quarter and full fiscal year, along with a 2027 outlook that includes projected sales growth and defined margin targets.

At a share price of US$91.03, Donaldson Company has seen short term momentum cool, with a 30 day share price return down 6.4%, even though the 90 day share price return is up 8.8% and the 1 year total shareholder return is 13.8%.

Spot fresh ideas alongside Donaldson Company by reviewing the 19 high quality undiscovered gems that have been hand picked for strong fundamentals and potential to break out.

For Donaldson Company, the recent pullback follows a period of strong share gains and higher reported earnings. Is the latest move pointing to a cooler view on the business, or simply a reset in sentiment before valuation catches up?

Most Popular Narrative: 7.9% Undervalued

Based on the most followed narrative, Donaldson Company’s fair value of $98.80 sits above the last close of $91.03. This frames the recent share pullback in a different light and puts more focus on the growth assumptions behind that estimate.

Strategic investments and M&A in high-margin, structurally growing segments (e.g., Life Sciences and Food & Beverage filtration) are expected to enhance margin mix and earnings quality, with Life Sciences segment margins improving notably and diversified R&D accelerating product innovation.

Read the complete narrative. Read the complete narrative.

Want to see what underpins that higher fair value for Donaldson Company? The narrative leans heavily on expanding margins, steadier earnings and a richer mix of filtration businesses. Curious which growth paths and profit assumptions carry the most weight in that story.

Result: Fair Value of $98.80 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Donaldson Company still faces key risks, including slower bioprocessing progress in Life Sciences and potential pressure on margins if input costs rise faster than its pricing power.

Find out about the key risks to this Donaldson Company narrative.

Next Steps

The mix of upside potential and flagged risks around Donaldson Company might feel mixed. Consider acting promptly to stress test that view against the facts using the full breakdown of 4 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Donaldson Company?

Do not stop with Donaldson Company. Use the Simply Wall Street Screener to line up your next potential opportunity before others start paying attention.

• Spot potential value opportunities before the crowd by scanning the 47 high quality undervalued stocks that currently trade below their estimated worth.
• Strengthen your defensive side by reviewing a list of solid balance sheet and fundamentals (52 results) that can help support returns when conditions get tougher.
• Target stability and income together by focusing on 82 resilient stocks with low risk scores that aim to keep volatility contained while you stay invested.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com